Biomarin Pharmaceutical Inc.’s filing revealed that its GVP, Chief Accounting Officer Burkhart Erin unloaded Company’s shares for reported $64260.0 on Aug 13 ’24. In the deal valued at $90.00 per share,714 shares were sold. As a result of this transaction, Burkhart Erin now holds 14,449 shares worth roughly $1.0 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Burkhart Erin bought 714 shares, generating $64,260 in total proceeds.
Before that, Mueller Brian sold 5,000 shares. Biomarin Pharmaceutical Inc. shares valued at $375,950 were divested by the EVP, Chief Financial Officer at a price of $75.19 per share. As a result of the transaction, Mueller Brian now holds 72,159 shares, worth roughly $4.98 million.
Bernstein upgraded its Biomarin Pharmaceutical Inc. [BMRN] rating to an Outperform from a a Mkt perform in a research note published on August 20, 2024; the price target was increased to $110 from $94. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who decreased its forecast for the stock in mid May from “an Outperform” to “a Neutral”. Evercore ISI began covering BMRN with “an Outperform” recommendation on May 14, 2024. Wells Fargo started covering the stock on November 15, 2023. It rated BMRN as “an Overweight”.
Price Performance Review of BMRN
On Monday, Biomarin Pharmaceutical Inc. [NASDAQ:BMRN] saw its stock fall -0.79% to $68.96. Over the last five days, the stock has lost -1.89%. Biomarin Pharmaceutical Inc. shares have fallen nearly -28.48% since the year began. Nevertheless, the stocks have fallen -21.00% over the past one year. While a 52-week high of $99.56 was reached on 01/08/24, a 52-week low of $67.75 was recorded on 09/24/24. SMA at 50 days reached $82.11, while 200 days put it at $85.37.
Levels Of Support And Resistance For BMRN Stock
The 24-hour chart illustrates a support level at 68.46, which if violated will result in even more drops to 67.96. On the upside, there is a resistance level at 69.36. A further resistance level may holdings at 69.76. The Relative Strength Index (RSI) on the 14-day chart is 29.24, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.99%. Stochastics %K at 24.25% indicates the stock is a holding.
How much short interest is there in Biomarin Pharmaceutical Inc.?
A steep rise in short interest was recorded in Biomarin Pharmaceutical Inc. stocks on 2024-09-13, dropping by -0.64 million shares to a total of 6.01 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.65 million shares. There was a decline of -10.7%, which implies that there is a negative sentiment for the stock.
